Norman Payson - Dec 21, 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Dec 21, 2022
Transactions value $
-$209,428
Form type
4
Date filed
12/22/2022, 03:59 PM
Previous filing
Dec 9, 2022
Next filing
Dec 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Sale -$209K -6.62K -2.32% $31.65 279K Dec 21, 2022 See footnote F1, F2, F3
holding PGNY Common Stock 122K Dec 21, 2022 See footnote F4
holding PGNY Common Stock 12.1K Dec 21, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.34 to $32.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F4 The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.